TARGETING THE NOVEL TXNRD1-CGAS-SASP AXIS TO ERADICATE STEMLIKE CELLS IN EPITHELIAL OVARIAN CANCER

$405,000FY2025Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators